Natco Pharma shares surged 5% to Rs 1,569 after filing an ANDA with the US FDA for a generic cancer drug. The company aims for 180 days of marketing exclusivity.
DIIs on a buying spree: 2025 sees 2nd-highest equity inflows in a decade
Domestic Institutional Investors are showing strong confidence in Indian stocks. They invested nearly Rs 2.94 lakh crore by early June 2025.